Efficacy and Safety of Bevacizumab for Treating Glioblastoma: A Systematic Review and Meta-Analysis of Phase II and III Randomized Controlled Trials
Sign Up to like & getrecommendations! Published in 2023 at "Cancer Investigation"
DOI: 10.1080/07357907.2023.2174261
Abstract: Abstract Objective To fully investigate the efficacy and safety of bevacizumab for glioblastoma. Methods Databases were searched for phase II/III randomized controlled trials treated with bevacizumab. Results Bevacizumab significantly improved the PFS in glioblastoma patients,… read more here.
Keywords: iii randomized; randomized controlled; bevacizumab; efficacy safety ... See more keywords
Efficacy and Safety of Bevacizumab Combined with Mitomycin C or 5-Fluorouracil in Primary Trabeculectomy: A Meta-Analysis of Randomized Clinical Trials
Sign Up to like & getrecommendations! Published in 2018 at "Ophthalmic Research"
DOI: 10.1159/000486576
Abstract: Aim: The objective of this study was to evaluate the efficacy and safety of bevacizumab combined with antimetabolite as an adjunctive therapy in primary trabeculectomy for glaucoma. Materials and Methods: PubMed, Cochrane Library, and EMBASE… read more here.
Keywords: bevacizumab; efficacy safety; safety; bevacizumab combined ... See more keywords
Efficacy and Safety of Bevacizumab Plus Erlotinib in Patients with Renal Medullary Carcinoma
Sign Up to like & getrecommendations! Published in 2021 at "Cancers"
DOI: 10.3390/cancers13092170
Abstract: Simple Summary Renal medullary carcinoma (RMC) is a rare and highly aggressive renal cell carcinoma, with a median survival of 13 months. Platinum-based chemotherapy is the recommended standard of care for RMC, but no effective… read more here.
Keywords: plus erlotinib; efficacy safety; erlotinib patients; safety bevacizumab ... See more keywords